Analysts await Penumbra, Inc. (NASDAQ:PEN) to report earnings on May, 09 for the fiscal quarter ending Mar 2016.

They expect $-0.06 EPS, down 100% or $0.06 from last year’s $n/a per share.

At the moment 4 analysts are watching Penumbra, Inc. (NASDAQ:PEN), 3 rate it “Buy”, 1 “Outperform”, 0 “Underperform”, 0 “Sell”, while 0 “Hold”.

Looking forward, for the quarter ending Jun-16, 4 analysts have a mean sales target of 56.57 million. For the quarter ending Sep-16, 4 analysts have a mean sales target of 59.54 million whilst for the year ending Dec-16, 4 analysts have a mean target of 232.97 million.

In terms of earnings per share, 4 analysts have a -0.09 EPS mean target for the quarter ending Jun-16, for the quarter ending Sep-16, 4 analysts have a -0.08 EPS mean target and for the quarter ending Sep-16 there are 4 estimates of -0.29 EPS.

The biggest institutional shareholders in Penumbra, Inc. include Fidelity Management and Research Company which owns 4 million shares in the company valued at $205.96 million. Redmile Group, LLC is the second biggest holder with 2 million shares currently valued at 82.74 million whilst Lord, Abbett & Co LLC has 692 K million shares valued at 37.24 million.

Total shares held by institutions as of the most recent company filings are 9,424,457 with a reported 1,804,107 bought and 367,576 sold. These holdings make up 31.58% of the company’s outstanding shares.

Currently insiders hold 4,015,583 shares in the business which makes up 13.40% of shares. The biggest holder currently is Mr. Adam Elsesser who owns 1,236,838 shares (4.13% of those outstanding), whilst Dr. Arani Bose, M.D. holds 745,662 (2.49% of shares outstanding) and Mr. James Pray holds 650,000 (2.17% of shares outstanding).

The stock increased 0.39% or $0.21 during the last trading session, hitting $54.78. Penumbra, Inc. (NASDAQ:PEN) has risen 30.78% over the past 6 months and is uptrending.